GlobalData publishes analysis of top 25 global pharma companies

The data and analytics company has tracked the market cap performance of the top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights

picture of

Breaking News

Catalent acquires Juniper Pharmaceuticals

The acquisition will strengthen the technology providers offerings in formulation development and oral dose ...

UK clinical research post-Brexit

Dr Sheuli Porkess, Deputy Chief Scientific Officer of the ABPI here discusses the future of clinical research as the UK ...

Karuna completes $42 million financing round

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed ...

Middle East and Africa pharma economy to reach US$38.8 bn by 2021

CPhI Middle East and Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government ...

Takeda shows significant profit dip in Q1

Takeda will be looking to Shire’s drug pipeline to bolster future sales after disappointing Q1 results, says GlobalData

DKSH signs exclusive distribution agreement with Abitec

The ingredients and specialty chemicals distributor has been selected to exclusively distribute a lipid excipient and ...

A new way of buying and selling APIs, additives, vitamins and excipients

Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and ...

Cambrex agrees to acquire Halo Pharma

The manufacturer of small molecules and generic APIs has agreed to acquire the dosage form CDMO

Is the west set to lose the innovation arms race?

New research finds that the US, EU & UK will lose all innovation leadership positions by 2029

Open tech standards hold the key to better sponsor-CRO collaboration

Sponsors are under ever-increasing pressure to reduce the cost of drug development while accelerating time-to-market, ...

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Global partnership to expand pharma biocatalysis uptake

Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading ...

The ‘Biosimilar Action Plan’

Another FDA move designed to chase value based pricing, says GlobalData

Grant awarded to doctors researching innovative PDX models in immuno-oncology

Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create b ...